Kriya Therapeutics - Unleashing the Power of Gene Therapy
Unleashing the Power of Gene Therapy
A FULLY INTEGRATED
GENE THERAPY ENGINE
Our platform consolidates critical infrastructure and technology needed to systematically advance the design, development, and manufacturing of gene therapies. We believe that scale is critical to generate the large volumes of data required to drive transformational improvements in the engineering and production of gene therapies.
Our proprietary computational engine, SIRVE™, integrates large volumes of data generated by Kriya’s engineering and screening platforms to support machine learning enabled analysis, intelligent product design, and the generation of novel component technologies.
Our cutting edge GMP manufacturing facility supports in-house production from early through late phase development, while empowering the design and implementation of novel technologies and processes that enable consistent manufacturing at large scale and low cost.
R & D
Our R&D engine accelerates the design and development of products from concept through clinic, leveraging our next generation sequencing platform and suite of proprietary immunological and bioanalytical assays to support high throughput screening and methodical candidate selection.
Our portfolios of gene therapies have the potential to revolutionize the treatment of diseases of high unmet need, with initial focus areas in ophthalmology, oncology, rare disease, and chronic disease. We build leading organizations in each one of these focus areas led by industry veterans with a track record of advancing products from concept through commercialization.
We focus on developing gene therapies for diseases with well-understood biology and established clinical endpoints, and where the durable expression of a particular therapeutic protein could have a transformative clinical impact. Our pipeline includes internally developed products as well as programs originated at leading academic institutions around the world.